Disease Burden Attributed to Drug use in the Nordic Countries: a Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2019

• Published in: International Journal of Mental Health and Addiction
• Main Authors: Agardh, Emilie, E., Allebeck, Peter, Knudsen, Ann Kristin Skrindo, Aronsson, Emma Amanda, Flodin, Pär, Eikemo, Terje Andreas, Bangah, Paul R., Skogen, Jens Christoffer, Gissler, Mika, Rönkä, Sanna, McGrath, John J., Sigurvinsdottir, Rannveig, Dadras, Omid, Deuba, Keshab, Hedna, Khedidja, Mentis, Alexios‑Fotios A., Sagoe, Dominic, Shiri, Rahman, Weye, Nanna Ørslev, Hay, Simon I., Murray, Christopher J. L., Naghavi, Mohsen, Pasovic, Maja, Vos, Theo, Wennberg, Peter, Danielsson, Anna‑Karin
• Format: Article in Journal/Newspaper
• Language: English
• Published: Springer 2023
• Subjects: Daly; Norway; Iceland
• Online Access: https://hdl.handle.net/11250/3092008; https://doi.org/10.1007/s11469-023-01131-w

The Nordic countries share similarities in many social and welfare domains, but drug policies have varied over time and between countries. We wanted to compare differences in mortality and disease burden attributed to drug use over time. Using results from the Global Burden of Disease (GBD) study, we extracted age-standardized estimates of deaths, DALYs, YLLs and YLDs per 100 000 population for Denmark, Finland, Iceland, Norway, and Sweden during the years 1990 to 2019. Among males, DALY rates in 2019 were highest in Finland and lowest in Iceland. Among females, DALY rates in 2019 were highest in Iceland and lowest in Sweden. Sweden have had the highest increase in burden since 1990, from 252 DALYs to 694 among males, and from 111 to 193 among females. Norway had a peak with highest level of all countries in 2001–2004 and thereafter a strong decline. Denmark have had the most constant burden over time, 566–600 DALYs among males from 1990 to 2010 and 210–240 DALYs among females. Strict drug policies in Nordic countries have not prevented an increase in some countries, so policies need to be reviewed. publishedVersion